TET2 c.4044+2T>A

Variant ID: 4-106183007-T-A

NM_001127208.2(TET2):c.4044+2T>A

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.

Nature Communications
Boy, Maxime M; Bisio, Valeria V; Zhao, Lin-Pierre LP; Guidez, Fabien F; Schell, Bérénice B; Lereclus, Emilie E; Henry, Guylaine G; Villemonteix, Juliette J; Rodrigues-Lima, Fernando F; Gagne, Katia K; Retiere, Christelle C; Larcher, Lise L; Kim, Rathana R; Clappier, Emmanuelle E; Sebert, Marie M; Mekinian, Arsène A; Fain, Olivier O; Caignard, Anne A; Espeli, Marion M; Balabanian, Karl K; Toubert, Antoine A; Fenaux, Pierre P; Ades, Lionel L; Dulphy, Nicolas N
Publication Date: 2023-02-03

Variant appearance in text: TET2: 4044+2T>A
PubMed Link: 36737440
Variant Present in the following documents:
  • 41467_2023_36193_MOESM1_ESM.pdf
View BVdb publication page



Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease.

Leukemia
Dawoud, Ahmed A Z AAZ; Gilbert, Rodney D RD; Tapper, William J WJ; Cross, Nicholas C P NCP
Publication Date: 2022-02

Variant appearance in text: TET2: 4044+2T>A
PubMed Link: 34413458
Variant Present in the following documents:
  • 41375_2021_1382_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page